Results 11 to 20 of about 18,379 (288)

Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia

open access: greenJAMA pediatrics, 2021
Importance Lifelong immunoglobulin replacement therapy (IRT) is standard-of-care treatment for congenital agammaglobulinemia but accrues high annual costs ($30 000-$90 000 per year) and decrements to quality of life over patients' life spans ...
Di Sun   +5 more
openalex   +3 more sources

Case Report: A novel de novo SPI1 mutation identified in a Chinese patient with agammaglobulinemia [PDF]

open access: yesFrontiers in Immunology
BackgroundPU.1 deficiency, also known as Autosomal Dominant Agammaglobulinemia-10 (AGM10), is a rare primary immunodeficiency caused by mutations in the SPI1 gene, leading to B cell deficiency and hypogammaglobulinemia.
Qi Peng   +16 more
doaj   +2 more sources

Purulent meningitis in X-linked agammaglobulinemia: one case report [PDF]

open access: yesFrontiers in Immunology
X-linked agammaglobulinemia (XLA) is characterized by a triad of primary immunodeficiency, profound hypogammaglobulinemia due to absent antibody production, and a consequent predisposition to severe and recurrent bacterial infections.
Anyi Ba   +5 more
doaj   +2 more sources

X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world

open access: yesWorld Allergy Organization Journal, 2019
Background: X-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications.
Zeinab A. El-Sayed   +50 more
doaj   +2 more sources

Disseminated Spiroplasma apis Infection in Patient with Agammaglobulinemia, France

open access: yesEmerging Infectious Diseases, 2018
We report a disseminated infection caused by Spiroplasma apis, a honeybee pathogen, in a patient in France who had X-linked agammaglobulinemia. Identification was challenging because initial bacterial cultures and direct examination by Gram staining were
Nicolas Etienne   +11 more
doaj   +2 more sources

Primera parte. Hombre de 45 años con neumonía grave, infección diseminada por citomegalovirus y agammaglobulinemia [PDF]

open access: yesBiomédica: revista del Instituto Nacional de Salud
Se trata de un paciente de sexo masculino de 45 años con tos persistente de cuatro meses de duración, acompañada de fiebre y una significativa pérdida de peso.
Mónica Fernandes Pineda   +1 more
doaj   +2 more sources

Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model [PDF]

open access: bronze, 2014
X-linked agammaglobulinemia (XLA) is an inherited immunodeficiency that results from mutations within the gene encoding Bruton’s tyrosine kinase (BTK). Many XLA-associated mutations affect splicing of BTK pre-mRNA and severely impair B cell development ...
Burcu Bestas   +20 more
openalex   +3 more sources

The prevalence of allergic manifestations in inborn errors of immunity: a retrospective cohort study [PDF]

open access: yesBMC Immunology
Background Inborn errors of immunity (IEIs) can exhibit variant clinical manifestations beyond the classic presentation of recurrent infections. Allergic diseases represent an important subset that can arise as the primary feature or coexist with IEIs ...
Hossein Esmaeilzadeh   +4 more
doaj   +2 more sources

Autosomal Recessive Agammaglobulinemia in Juvenile Idiopathic Arthritis: A Case Report [PDF]

open access: yesReviews in Clinical Medicine, 2020
The B lymphocyte developmental blocks agammaglobulinemia, leading to peripheral B cell depletion and plasma immunoglobulin reduction. Agammaglobulinemia is a rare yet severe disease since it is presented with recurrent sinopulmonary and skin, central ...
Azadeh Zare Feizabadi   +2 more
doaj   +2 more sources

Clinical Case of Agammaglobulinemia Late Diagnosis in Preschool Child

open access: yesПедиатрическая фармакология, 2022
Background. Agammaglobulinemia is a disease from the group of primary immune deficiencies with impaired antibodies production characterized by significant decrease or complete absence of B-cells.
Elena S. Kolevatova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy